Latest Breaking News On - Imexpharm pharmaceutical joint stock company - Page 1 : comparemela.com

Pharma industry growth slows down By Minh Son   February 1, 2021 | 08:59 am GMT+7 SSI analysts estimated the pharmaceutical industry to grow by 15 percent in 2021. Photo by Pixabay. The pharmaceutical industry’s revenues rose by just 3 percent in 2020, down from an average of 11.8 percent in the previous five years. But it was a notable year for mergers and acquisitions. According to analysts at SSI Securities, the total value of M&A was VND1.68 trillion ($73 million) last year and involved a number of foreign investors. In May, South Korean conglomerate SK Group, which makes anti-cancer and cardiovascular drugs and mental health medications, paid VND920 billion to acquire a 25 percent stake in Imexpharm Pharmaceutical Joint Stock Company.

South koreaSouth koreanSk groupHa tay pharmaceutical joint stock company hatapharImexpharm pharmaceutical joint stock companyImexpharm pharmaceutical joint stockAska pharmaceuticalPharma industry growth slows down vnexpress internationalதெற்கு கொரியாதெற்கு கொரியன்ஸ்க் குழுஅஷ்க மருந்து